Pharmacokinetics and Pharmacodynamics Practice Questions

Q: Which of the following medications inhibits the effect of oral contraceptive pills?

Rifampicin. **Explanation:** **1. Why Rifampicin is the Correct Answer:** Rifampicin is a potent **inducer of Cytochrome P450 (CYP450) enzymes**, specifically the CYP3A4 isoform. Oral contraceptive pills (OCPs) contain estrogen and progestin, which are metabolized by these liver enzymes. When Rifampicin induces these enzymes, it accelerates the metabolism and clearance of the hormones, leading to sub-therapeutic plasma levels. This results in **contraceptive failure** and breakthrough bleeding. It is the most notorious drug for this interaction. **2. Why the Other Options are Incorrect:** * **B. Cimetidine:** This is a potent **enzyme inhibitor**. It would typically increase the plasma levels of drugs metabolized by the liver, potentially increasing the side effects of OCPs rather than inhibiting their efficacy. * **C. Ethambutol:** Unlike Rifampicin, Ethambutol is an antitubercular drug that does not significantly affect the hepatic microsomal enzyme system. It has no documented interaction with OCPs. * **D. Propranolol:** This is a non-selective beta-blocker. While it is metabolized by the liver, it does not induce or inhibit enzymes in a way that would diminish the clinical effect of OCPs. **3. High-Yield Clinical Pearls for NEET-PG:** * **The "Inducer" Mnemonic:** Remember **GPRS Cell Phone** (Griseofulvin, Phenytoin, Rifampicin, Smoking, Carbamazepine, Phenobarbitone) as the classic CYP450 inducers. * **Patient Counseling:** Patients on OCPs starting Rifampicin therapy (e.g., for Tuberculosis) must be advised to use an **alternative/barrier method** of contraception. * **Broad Spectrum:** Rifampicin is a "pan-inducer," affecting almost all CYP families (1A2, 2C9, 2C19, 3A4).

Q: All of the following are examples of mechanism-based inhibition, EXCEPT?

Statins on HMG-CoA reductase. ### Explanation **Mechanism-based inhibition**, also known as **suicide inhibition** or irreversible covalent inhibition, occurs when an enzyme converts an initially inactive inhibitor (a "prodrug" or substrate analog) into a reactive intermediate. This intermediate then binds covalently and irreversibly to the enzyme's active site, permanently "killing" the enzyme. **Why Statins are the Correct Answer:** Statins (e.g., Atorvastatin) are **competitive, reversible inhibitors** of HMG-CoA reductase. They structurally resemble the natural substrate (HMG-CoA) and compete for the same binding site. Because the binding is non-covalent and reversible, they do not qualify as suicide inhibitors. **Analysis of Incorrect Options (Suicide Inhibitors):** * **Aspirin:** It irreversibly acetylates the serine residue at the active site of **Cyclooxygenase (COX-1 and COX-2)**. This is a classic example of covalent modification. * **Allopurinol:** It is converted by **Xanthine Oxidase** into its active metabolite, **Alloxanthine (Oxypurinol)**. Alloxanthine then binds tightly and irreversibly to the molybdenum ion in the enzyme's active site. * **Difluoromethylornithine (DFMO/Eflornithine):** It is a substrate analog that is activated by **Ornithine Decarboxylase**, leading to irreversible enzyme inactivation. It is used clinically for African Trypanosomiasis and hirsutism. **High-Yield NEET-PG Pearls:** * **Other Suicide Inhibitors:** Clavulanic acid (on $\beta$-lactamase), Selegiline (on MAO-B), Disulfiram (on Aldehyde dehydrogenase), and 5-Fluorouracil (on Thymidylate synthase). * **Key Distinction:** In competitive inhibition (Statins), $V_{max}$ remains unchanged while $K_m$ increases. In suicide inhibition, the enzyme is permanently inactivated, effectively decreasing the total enzyme concentration ($V_{max}$ decreases).

Q: Which of the following best describes the ionization state of a drug when the pH of the environment equals the drug's pKa?

The drug exists as 50% ionized and 50% unionized.. ### Explanation The ionization state of a drug is governed by the **Henderson-Hasselbalch Equation**, which describes the relationship between the pH of the medium, the pKa of the drug, and the ratio of its ionized to unionized forms. **Why Option A is Correct:** The Henderson-Hasselbalch equation is expressed as: * **For Weak Acids:** $pH = pKa + \log \frac{[Ionized]}{[Unionized]}$ * **For Weak Bases:** $pH = pKa + \log \frac{[Unionized]}{[Ionized]}$ When the **pH equals the pKa**, the value of $\log \frac{[Ionized]}{[Unionized]}$ (or vice versa) becomes **zero**. Since $\log(1) = 0$, the ratio of ionized to unionized drug must be **1:1**. Therefore, exactly **50%** of the drug exists in the ionized form and **50%** in the unionized form. **Why Other Options are Incorrect:** * **Options B & C:** These ratios occur when there is a difference between pH and pKa. For instance, a 1-unit difference in pH results in a 10:1 ratio (approx. 90% vs 10%), and a 2-unit difference results in a 100:1 ratio (approx. 99% vs 1%). * **Option D:** A drug is never "completely" ionized in biological systems, though it may approach 99.9% if the pH-pKa gradient is very high. **High-Yield Clinical Pearls for NEET-PG:** 1. **Lipid Solubility:** Only the **unionized** form of a drug is lipid-soluble and can cross biological membranes (e.g., Blood-Brain Barrier, GI tract). 2. **Ion Trapping:** This principle is used in toxicology. To treat **Aspirin (weak acid)** poisoning, we **alkalinize the urine** (using Sodium Bicarbonate). This increases the ionized fraction of the drug in the renal tubules, preventing reabsorption and enhancing excretion. 3. **Memory Aid:** "Like is unionized in like." (Acidic drugs are unionized in acidic pH; Basic drugs are unionized in basic pH).

Q: High continuous doses of agonist drugs cause which of the following?

Down-regulation of receptors. **Explanation:** The correct answer is **A. Down-regulation of receptors.** This phenomenon is a classic example of **receptor regulation**, a homeostatic mechanism the body uses to maintain equilibrium. When a cell is exposed to high, continuous concentrations of an **agonist**, the receptors are overstimulated. To protect the cell from excessive activation, the body reduces the number or sensitivity of these receptors. This occurs through: 1. **Internalization:** Receptors are moved from the cell membrane into the cytoplasm via endocytosis. 2. **Degradation:** Receptors are broken down by lysosomes. 3. **Reduced Synthesis:** Decreased production of new receptor proteins. **Why the other options are incorrect:** * **B. Up-regulation of receptors:** This is the opposite process. It occurs in response to chronic exposure to **antagonists** (blockers) or due to denervation. When receptors are blocked, the cell compensates by increasing the number of receptors to catch any available signal. * **C. Depends on the dose:** While the *extent* of down-regulation is dose-dependent, the *direction* of the physiological response to a continuous agonist is consistently down-regulation. **High-Yield NEET-PG Pearls:** * **Tachyphylaxis:** A rapid form of desensitization (e.g., repeated doses of Ephedrine or Tyramine). * **Tolerance:** A gradual decrease in responsiveness to a drug (e.g., Morphine, Nitrates) often mediated by down-regulation. * **Clinical Consequence:** Sudden withdrawal of an antagonist (like Propranolol) can lead to "rebound hypertension" or angina because the receptors were **up-regulated** during treatment, making the cell hypersensitive to endogenous ligands.

Q: A drug that shifts the dose-response curve to the left has:

More potency. ### Explanation **1. Why "More Potency" is Correct:** Potency refers to the amount of drug (dose) required to produce a specific effect of a given intensity. On a graded dose-response curve (DRC), the x-axis represents the dose/concentration (usually in log scale). When a drug's DRC shifts to the **left**, it indicates that a **lower dose** is required to achieve the same response (e.g., the $ED_{50}$). Therefore, a leftward shift signifies higher potency. **2. Why Other Options are Incorrect:** * **Option A (More Efficacy):** Efficacy is the maximal response ($E_{max}$) a drug can produce. On a DRC, efficacy is represented by the **height (y-axis)** of the curve. A drug with more efficacy would have a taller curve, not necessarily a leftward shift. * **Option C (More Safety):** Safety is typically measured by the **Therapeutic Index** ($LD_{50}/ED_{50}$). A shift to the left only tells us about the drug's power at low doses; it does not provide information about the lethal dose or the margin of safety unless compared with the toxicity curve. **3. NEET-PG High-Yield Pearls:** * **Potency vs. Efficacy:** Efficacy is clinically more important than potency. For example, Furosemide is more efficacious than Chlorothiazide because it can remove more fluid, regardless of the milligram dose used. * **Competitive Antagonists:** These shift the DRC of an agonist to the **right** (increasing $ED_{50}$, decreasing potency) without affecting the maximal response (efficacy). * **Non-competitive Antagonists:** These shift the DRC **downwards**, decreasing the maximal response (efficacy) without necessarily changing the $ED_{50}$ (potency). * **$ED_{50}$ (Median Effective Dose):** The dose at which 50% of the maximal effect is observed. It is the standard measure used to compare the potency of drugs.

Q: Maintenance dose is primarily dependent on which pharmacokinetic parameter?

Clearance. **Explanation:** The primary goal of a **maintenance dose** is to maintain a steady-state plasma concentration ($C_{ss}$) of a drug, where the rate of drug administration equals the rate of drug elimination. **1. Why Clearance (A) is correct:** The mathematical formula for maintenance dose is: $$\text{Maintenance Dose} = \frac{C_{ss} \times \text{Clearance}}{\text{Bioavailability (F)}}$$ Since the dose is intended to replace only the amount of drug lost from the body, it is directly proportional to **Clearance (CL)**. If a patient has impaired clearance (e.g., renal failure), the maintenance dose must be decreased to avoid toxicity. **2. Why other options are incorrect:** * **Volume of Distribution (Vd):** This parameter determines the **Loading Dose**, not the maintenance dose. Vd relates the total amount of drug in the body to the plasma concentration but does not account for the rate of elimination over time. * **Metabolism:** While metabolism is a component of clearance, it is not the only one (excretion also plays a role). Clearance is the more comprehensive pharmacokinetic parameter used for dosing calculations. * **Absorption:** This affects the bioavailability (F) and the peak concentration, but the maintenance dose is calculated based on the target steady-state level regardless of how the drug enters the systemic circulation (though F is used as a correction factor). **Clinical Pearls for NEET-PG:** * **Loading Dose** = $(Vd \times \text{Target } C_{ss}) / F$. Think: *Vd for Loading, Clearance for Maintenance.* * **Steady State:** It takes approximately **4 to 5 half-lives** to reach steady-state concentration. * **Half-life ($t_{1/2}$):** Is determined by both Vd and CL ($t_{1/2} = 0.693 \times Vd / CL$).

Q: Which of the following is NOT a phase I drug metabolism reaction?

Sulfation. Drug metabolism (biotransformation) typically occurs in two phases to make lipophilic drugs more water-soluble for excretion. **Why Sulfation is the correct answer:** **Sulfation** is a **Phase II (Conjugation) reaction**. Phase II reactions involve the attachment of an endogenous hydrophilic group (like glucuronic acid, sulfate, or glutathione) to a drug or its Phase I metabolite. This significantly increases water solubility and usually results in pharmacological inactivation. Other Phase II reactions include Glucuronidation (most common), Acetylation, and Methylation. **Why the other options are incorrect:** Phase I reactions (Functionalization) introduce or expose a functional group (–OH, –NH2, –SH) on the drug molecule. * **Oxidation (Option A):** The most common Phase I reaction, primarily mediated by Cytochrome P450 enzymes. * **Deamination (Option B):** The removal of an amino group from a molecule, a classic Phase I process (e.g., metabolism of adrenaline by MAO). * **Dealkylation (Option C):** The removal of alkyl groups (like methyl or ethyl) from a drug, also a Phase I oxidative process. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Phase II:** **"S-G-A-M"** (Sulfation, Glucuronidation, Acetylation, Methylation). * **Microsomal vs. Non-microsomal:** Most Phase I and Glucuronidation occur in the Smooth ER (microsomal). Sulfation and Acetylation are **non-microsomal** (cytosolic). * **Exception to Inactivation:** Phase II usually inactivates drugs, but **Morphine-6-glucuronide** is a Phase II metabolite that is *more* active than morphine. * **Grey Baby Syndrome:** Occurs due to deficient Glucuronidation of Chloramphenicol in neonates.

Question 1

Arrange the following drugs according to their half-life in increasing order: 1. Amiodarone 2. Adenosine 3. Esmolol 4. Omeprazole

Accepted Answer

2-3-4-1

Answer

1-2-4-3

Answer

2-3-1-4

Answer

4-3-1-2

Question 2

Which of the following medications inhibits the effect of oral contraceptive pills?

Accepted Answer

Rifampicin

Answer

Cimetidine

Answer

Ethambutol

Answer

Propranolol

Question 3

A 500-mg dose of a drug has therapeutic efficacy for 6 hours. If the half-life of the drug is 8 hours, for how long would a 1-gm dose be effective?

Accepted Answer

14 hours

Answer

12 hours

Answer

16 hours

Answer

24 hours

Question 4

All of the following are examples of mechanism-based inhibition, EXCEPT?

Accepted Answer

Statins on HMG-CoA reductase

Answer

Aspirin on cyclooxygenase

Answer

Allopurinol on Xanthine oxidase

Answer

Difluoromethylornithine on ornithine decarboxylase

Question 5

Which of the following best describes the ionization state of a drug when the pH of the environment equals the drug's pKa?

Accepted Answer

The drug exists as 50% ionized and 50% unionized.

Answer

The drug exists as 25% ionized and 75% unionized.

Answer

The drug exists as 75% ionized and 25% unionized.

Answer

The drug is completely ionized.

Question 6

In an alcoholic individual, tolerance to alcohol that disappears as rapidly as it develops is known as:

Accepted Answer

Pharmacokinetic tolerance

Answer

Cellular tolerance

Answer

Pharmacodynamic tolerance

Answer

Behavioural tolerance

Question 7

High continuous doses of agonist drugs cause which of the following?

Accepted Answer

Down-regulation of receptors

Answer

Up-regulation of receptors

Answer

Depends on the dose

Answer

None of the above

Question 8

A drug that shifts the dose-response curve to the left has:

Accepted Answer

More potency

Answer

More efficacy

Answer

More safety

Answer

None of the above

Question 9

Maintenance dose is primarily dependent on which pharmacokinetic parameter?

Accepted Answer

Clearance

Answer

Volume of distribution

Answer

Metabolism

Answer

Absorption

Question 10

Which of the following is NOT a phase I drug metabolism reaction?

Accepted Answer

Sulfation

Answer

Oxidation

Answer

Deamination

Answer

Dealkylation

Pharmacokinetics and Pharmacodynamics — MCQs

Pharmacokinetics and Pharmacodynamics — MCQs

On this page

Practice by Chapter

Want unlimited practice?